Supplementary Table 2 from ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer

Authors :: Wafik S. El-Deiry
Lanlan Zhou
Anna Louie
Isacco Ferrarini
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table S2: differential blood cell count of mice treated with ONC212, 2-DG, or the combination of both agents.

Full Text Access

Tools